September 13, 2026 Teclistamab Shows Higher Response Rates in High-Risk Smoldering Multiple Myeloma Trial
September 1, 2026 Atezolizumab in Early-Stage Triple-Negative Breast Cancer: NSABP B-59/GeparDouze Trial Results and Biomarker Analysis
August 31, 2026 New Calculator Predicts Heart Failure Treatment Effects on Blood Pressure and Kidney Function
August 16, 2026 Multimodal Aging Clocks Reveal Tissue Morphological Changes and Physiological Fitness
